{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:46:45Z","timestamp":1788058005021,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.amjcard.2021.04.040","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T07:32:23Z","timestamp":1623483143000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-1736","authenticated-orcid":false,"given":"D.H. Frank","family":"Gommans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Etienne","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fouraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Heijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek W.A.","family":"Verheugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.M.","family":"Kofflard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2021.04.040_bib0001","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0002","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/heartjnl-2016-309900","article-title":"High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy","volume":"103","author":"Gommans","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amjcard.2018.04.020","article-title":"Prediction of extensive fibrosis in Hypertrophic Cardiomyopathy","volume":"122","author":"Gommans","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0006","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jacc.2013.03.055","article-title":"Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy","volume":"62","author":"Kubo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0007","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjcard.2013.12.033","article-title":"Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk","volume":"113","author":"Cramer","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0008","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/heart.89.6.659","article-title":"Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy","volume":"89","author":"Sato","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0009","doi-asserted-by":"crossref","first-page":"w14285","DOI":"10.4414\/smw.2016.14285","article-title":"Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy","volume":"146","author":"Hasler","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005968","article-title":"Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study","volume":"4","author":"Nakamura","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0011","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/heartjnl-2019-315818","article-title":"Exercise and myocardial injury in hypertrophic cardiomyopathy","volume":"106","author":"Cramer","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ejhf.669","article-title":"Variability of biomarkers in patients with chronic heart failure and healthy controls","volume":"19","author":"Meijers","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA cardiol"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0014","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2020.11.030","article-title":"After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is this Paradigm Under-Recognized in the Literature?","volume":"142","author":"Maron","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.04.040_bib0015","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921004203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921004203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:38:35Z","timestamp":1757572715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914921004203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":15,"alternative-id":["S0002914921004203"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.04.040","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}